Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension
Phase 4
Completed
- Conditions
- Hypertension
- Registration Number
- NCT00060931
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
Evaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 501
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change from baseline in HbA1c at 5 months 5 months
- Secondary Outcome Measures
Name Time Method Blood pressure at 3 and 5 months Body weight at 3 and 5 months Lab levels (glucose, insulin, triglycerides, cholesterol, and albumin:creatinine ratio) at 3 and 5 months. 5 months
Trial Locations
- Locations (1)
GSK Investigational Site
🇺🇸Springfield, Virginia, United States
GSK Investigational Site🇺🇸Springfield, Virginia, United States